Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
about
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunityEffect of rifaximin on gut microbiota composition in advanced liver disease and its complicationsBiliary Mucosal Barrier and MicrobiomeImplication of the intestinal microbiome in complications of cirrhosisCirrhosis and dysbiosis: New insights from next-generation sequencing.The dormant blood microbiome in chronic, inflammatory diseases.The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection.Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR SpectroscopyIntestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure.TGF-β1 improves mucosal IgA dysfunction and dysbiosis following intestinal ischaemia-reperfusion in miceMetabonomics Research Progress on Liver Diseases.Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability.Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study.Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism.Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.Lactobacillus sakei K17, an inducer of IL-10 expression in antigen-presenting cells, attenuates TNBS-induced colitis in mice.Citrobacter braakii bacteremia-induced septic shock after colonoscopy preparation with polyethylene glycol in a critically ill patient: a case report.What is new about diet in hepatic encephalopathy.Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review.Role of systemic inflammation in cirrhosis: From pathogenesis to prognosis.Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases.Preserved Gut Microbial Diversity Accompanies Upregulation of TGR5 and Hepatobiliary Transporters in Bile Acid-Treated Animals Receiving Parenteral Nutrition.The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives.Recent developments in understanding the role of the gut microbiota in brain health and disease.Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.Lipopolysaccharide promotes angiogenesis in mice model of HCC by stimulating hepatic stellate cell activation via TLR4 pathway.Disruption of the gut-liver axis in the pathogenesis of acute-on-chronic liver failure.Gut Microbiota Profiling and Gut-Brain Crosstalk in Children Affected by Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B.Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy.Immunodysfunction in Acute-on-Chronic Liver FailureClinical impact of microbiome in patients with decompensated cirrhosisRebuilding the Gut Microbiota Ecosystem
P2860
Q26773267-E56928FD-CF91-4615-AF96-1D80D518705CQ26775927-F1DB799E-5D42-4DC6-86DB-0822AAB3E45AQ26782887-06A2BE11-8D0C-41B1-8A46-0ECA6ED5A893Q28068832-A4C266C2-D1AB-4411-BC0E-21490B32E62BQ30278800-73CD4080-1052-44D2-8306-B39D3A8926ABQ34474989-F8574DF1-3379-4C30-A362-313BF4D634F2Q35953201-B5BA0212-1E99-4E8F-97F1-A78BB54D89F4Q36001287-ADEF816D-DE09-4039-AAAC-9324CB56CCD0Q36012032-4C3C6DB5-2E2C-49F8-9E42-7CED44B30B22Q36188682-98DE200A-0C83-442C-BE1C-5D85255A98DAQ36942337-81FEF035-63C4-4AFE-A284-1EFDA5199CF1Q37683642-DE9D4CD2-61BD-441C-9FF7-B91A13582326Q38510131-034B842C-1238-496B-8568-14BA8C433F16Q38708565-BFBCE03E-C8B7-489F-A887-8A5F0EF174EDQ39168770-F22BCC34-FDEF-4FC7-9F5E-DB8028AF2298Q39249817-6AB58E93-8141-42B2-B407-66E0A8F65953Q39417780-03FD7832-093F-4CCA-B001-4615071B2B42Q40264910-BD0032A3-32EA-4C1E-8FA8-29FC6A0E56E9Q40486028-D1856F26-DC0F-4FE9-82AF-39247AEE6F01Q41698366-9F04E7EF-1D2A-4F6A-8AB4-33EDD74E7952Q42042373-238B0E30-4A40-4DD4-A012-3E7332D10970Q46474665-69029656-F631-49DE-B202-C669481D54F8Q46504486-ECD683C3-97CF-43B0-9741-54959FF5B4ACQ47596377-6154176B-B254-4510-B5E8-C32C3CB8376AQ47808638-779B5683-D6FF-46E4-A249-59E41A469B88Q48182745-3DAA2B8F-6667-4BE5-B913-A3BEE5F2BAE4Q50074560-E7C98015-11F9-46B5-B563-ED94DB040E3EQ50099829-E70D2036-B376-40E4-AEF3-50FD5B882961Q52568341-BB6D0FE7-AB27-4C3A-A354-F69D0FD413B2Q54202324-EF257E1F-0600-42AE-9690-11C1026E7616Q54967548-9049431F-6228-4D40-9A0C-1150D7914780Q57824681-CE2D2CD6-386B-4A01-85D7-02218DCFF593Q58740370-1D9E21C3-2048-4588-9A68-20B96E7CA059Q58796769-C7E53964-1D01-4A17-93C9-AB26D9BCA96A
P2860
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@ast
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@en
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@nl
type
label
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@ast
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@en
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@nl
prefLabel
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@ast
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@en
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@nl
P2093
P2860
P50
P1476
Microbiota and the gut-liver a ...... on and infection in cirrhosis.
@en
P2093
Michela Giusto
Valerio Giannelli
Vincenza Di Gregorio
P2860
P304
16795-16810
P356
10.3748/WJG.V20.I45.16795
P407
P577
2014-12-01T00:00:00Z